Ireland Supplementary Protection Certificates

Supplementary Protection Certificates in Ireland

These international patent data are derived from patent families, based on US drug-patent linkages. Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.

Country	Patent Number	Supplementary Protection Certificate	SPC Country	SPC Description	SPC Expiration
European Patent Office	2323972	2019/013	Ireland	PRODUCT NAME: ERAVACYCLINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; NAT REGISTRATION NO/DATE: EU/1/18/1312 20180920
European Patent Office	1567147	2018/016	Ireland	PRODUCT NAME: PADELIPORFIN AS A DIPOTASSIUM SALT; REGISTRATION NO/DATE: EU/1/17/1228 20171110
European Patent Office	2215124	2016/025	Ireland	PRODUCT NAME: EVOLOCUMAB; REGISTRATION NO/DATE: EU/1/15/1016/001 EU/1/15/1016/005 20150717
European Patent Office	3106463	2020/009	Ireland	PRODUCT NAME: LAROTRECTINIB AND/OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PARTICULARLY LAROTRECTINIB SULFATE INCLUDING LAROTRECTINIB HYDROGEN SULFATE; REGISTRATION NO/DATE: EU/1/19/1385 20190923
European Patent Office	3150586	2020/021	Ireland	PRODUCT NAME: COBICISTAT OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, DARUNAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, IN PARTICULAR DARUNAVIR ETHANOLATE, AND EMTRICITABINE OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF; REGISTRATION NO/DATE: EU/1/17/1225 20170925